381 related articles for article (PubMed ID: 15319330)
1. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
[TBL] [Abstract][Full Text] [Related]
2. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
[TBL] [Abstract][Full Text] [Related]
3. Differences in the metabolism and pharmacokinetics of two structurally similar PPAR agonists in dogs: involvement of taurine conjugation.
Kim MS; Shen Z; Kochansky C; Lynn K; Wang S; Wang Z; Hora D; Brunner J; Franklin RB; Vincent SH
Xenobiotica; 2004 Jul; 34(7):665-74. PubMed ID: 15672754
[TBL] [Abstract][Full Text] [Related]
4. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor alpha agonist in preclinical species and human.
Frederick KS; Maurer TS; Kalgutkar AS; Royer LJ; Francone OL; Winter SM; Terra SG; Chen D; Gao X
Xenobiotica; 2009 Oct; 39(10):766-81. PubMed ID: 19622022
[TBL] [Abstract][Full Text] [Related]
6. Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats.
Wong H; Lehman-McKeeman LD; Grubb MF; Grossman SJ; Bhaskaran VM; Solon EG; Shen HS; Gerson RJ; Car BD; Zhao B; Gemzik B
Toxicol Sci; 2005 Apr; 84(2):232-42. PubMed ID: 15673846
[TBL] [Abstract][Full Text] [Related]
7. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.
Oana F; Takeda H; Hayakawa K; Matsuzawa A; Akahane S; Isaji M; Akahane M
Metabolism; 2005 Aug; 54(8):995-1001. PubMed ID: 16092047
[TBL] [Abstract][Full Text] [Related]
8. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.
Osabe M; Sugatani J; Fukuyama T; Ikushiro S; Ikari A; Miwa M
Drug Metab Dispos; 2008 Feb; 36(2):294-302. PubMed ID: 17967931
[TBL] [Abstract][Full Text] [Related]
9. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
Chaudhary IP; Tuntaterdtum S; McNamara PJ; Robertson LW; Blouin RA
J Pharmacol Exp Ther; 1993 Jun; 265(3):1333-8. PubMed ID: 8510012
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
[TBL] [Abstract][Full Text] [Related]
12. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
[TBL] [Abstract][Full Text] [Related]
13. Glucuronidation of anticancer prodrug PR-104A: species differences, identification of human UDP-glucuronosyltransferases, and implications for therapy.
Gu Y; Tingle MD; Wilson WR
J Pharmacol Exp Ther; 2011 Jun; 337(3):692-702. PubMed ID: 21427202
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of peroxisome proliferator-activated receptor alpha and liver fatty acid binding protein after partial hepatectomy of rats and mice.
Skrtic S; Carlsson L; Ljungberg A; Lindén D; Michalik L; Wahli W; Oscarsson J
Liver Int; 2005 Feb; 25(1):33-40. PubMed ID: 15698396
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
16. Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences.
Wen Z; Martin DE; Bullock P; Lee KH; Smith PC
Drug Metab Dispos; 2007 Mar; 35(3):440-8. PubMed ID: 17151190
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats with acute hepatitis induced by d-galactosamine/lipopolysaccharide or CCl(4).
Kang HE; Kim YW; Sohn SI; Baek SR; Lee JW; Kim SG; Lee I; Lee MG
Xenobiotica; 2010 Jun; 40(6):424-36. PubMed ID: 20350053
[TBL] [Abstract][Full Text] [Related]
18. Species differences in UDP-glucuronosyltransferase activities in mice and rats.
Shiratani H; Katoh M; Nakajima M; Yokoi T
Drug Metab Dispos; 2008 Sep; 36(9):1745-52. PubMed ID: 18505787
[TBL] [Abstract][Full Text] [Related]
19. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in insulin receptor mRNA and protein expression in genetically obese Zucker rats.
Amessou M; Tahiri K; Chauvet G; Desbuquois B
Diabetes Metab; 2010 Apr; 36(2):120-8. PubMed ID: 20149705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
